110 related articles for article (PubMed ID: 2920965)
1. Gynecologic cancer treated with a chemotherapy regimen containing cisplatin.
Wheelock JB
Gynecol Oncol; 1989 Mar; 32(3):401. PubMed ID: 2920965
[No Abstract] [Full Text] [Related]
2. Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclitaxel and carboplatin.
Yahata H; Kobayashi H; Sonoda K; Shimokawa M; Ohgami T; Saito T; Ogawa S; Sakai K; Ichinoe A; Ueoka Y; Hasuo Y; Nishida M; Masuda S; Kato K
Int J Clin Oncol; 2016 Jun; 21(3):491-7. PubMed ID: 26662632
[TBL] [Abstract][Full Text] [Related]
3. Combination antiemetic therapy in cisplatin-induced nausea and vomiting.
Krebs HB; Myers MB; Wheelock JB; Goplerud DR
Cancer; 1985 Jun; 55(11):2645-8. PubMed ID: 3888367
[TBL] [Abstract][Full Text] [Related]
4. The antiemetic efficacy of oral ondansetron plus intravenous dexamethasone in patients with gynecologic malignancies receiving carboplatin-based chemotherapy.
Markman M; Kennedy A; Webster K; Peterson G; Kulp B; Belinson J
Gynecol Oncol; 2000 Jul; 78(1):43-6. PubMed ID: 10873408
[TBL] [Abstract][Full Text] [Related]
5. Impact of chemotherapy-induced nausea and vomiting on quality of life in indonesian patients with gynecologic cancer.
Perwitasari DA; Atthobari J; Mustofa M; Dwiprahasto I; Hakimi M; Gelderblom H; Putter H; Nortier JW; Guchelaar HJ; Kaptein AA
Int J Gynecol Cancer; 2012 Jan; 22(1):139-45. PubMed ID: 22080888
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of palonosetron plus dexamethasone in preventing chemotherapy-induced nausea and emesis in patients receiving carboplatin-based chemotherapy for gynecologic cancers: a phase II study by the West Japan Gynecologic Oncology Group (WJGOG 131).
Nishio S; Aihara S; Shimokawa M; Fujishita A; Taniguchi S; Hachisuga T; Yanazume S; Kobayashi H; Murakami F; Numa F; Kotera K; Okura N; Toki N; Yokoyama M; Ushijima K
J Gynecol Oncol; 2018 Sep; 29(5):e77. PubMed ID: 30022637
[TBL] [Abstract][Full Text] [Related]
7. Pentobarbital's effect in a combination antiemetic regimen for cisplatin induced nausea and vomiting.
Wheelock JB
J Miss State Med Assoc; 1989 Jan; 30(1):5-8. PubMed ID: 2647995
[TBL] [Abstract][Full Text] [Related]
8. Comparison of oral versus intravenous ramosetron in prevention of acute cisplatin-induced emesis: a randomized controlled trial.
Tantipalakorn C; Srisomboon J; Thienthong H; Pantusart A; Suprasert P; Saereesongkhun C; Eamtang S; Sutthichat A; Pautad N
J Med Assoc Thai; 2004 Feb; 87(2):119-25. PubMed ID: 15061293
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of acupuncture in prevention of delayed chemotherapy induced nausea and vomiting in gynecologic cancer patients.
Rithirangsriroj K; Manchana T; Akkayagorn L
Gynecol Oncol; 2015 Jan; 136(1):82-6. PubMed ID: 25449310
[TBL] [Abstract][Full Text] [Related]
10. [A randomized cross-over comparative study of granisetron alone and combination of granisetron, methylprednisolone and droperidol as antiemetic prophilaxis in CDDP-based chemotherapy for gynecologic cancer].
Wataba K; Sagae S; Fukunaka N; Sugimura M; Akutagawa N; Hayashi T; Yamana K; Nakamura T; Terasawa K; Mizumoto H; Kitajima Y; Kudo R
Gan To Kagaku Ryoho; 1997 Apr; 24(6):691-7. PubMed ID: 9126306
[TBL] [Abstract][Full Text] [Related]
11. Effect of acupressure on chemotherapy-induced nausea and vomiting in gynecologic cancer patients in Turkey.
Taspinar A; Sirin A
Eur J Oncol Nurs; 2010 Feb; 14(1):49-54. PubMed ID: 19748316
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of antiemetic triplet therapy with aprepitant, palonosetron, and dexamethasone for gynecologic cancer patients receiving carboplatin and paclitaxel: a prospective single-arm study.
Ito F; Furukawa N
Support Care Cancer; 2017 Jun; 25(6):1941-1945. PubMed ID: 28160077
[TBL] [Abstract][Full Text] [Related]
13. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
[TBL] [Abstract][Full Text] [Related]
14. Increased nephrotoxicity of combination taxol and cisplatin chemotherapy in gynecologic cancers as compared to cisplatin alone.
Merouani A; Davidson SA; Schrier RW
Am J Nephrol; 1997; 17(1):53-8. PubMed ID: 9057954
[TBL] [Abstract][Full Text] [Related]
15. Influence on erythropoietin levels of treatment with cisplatinum-endoxan.
Lechner W; Artner-Dworzak E; Sölder E; Sachsenmaier M; Kölle D; Moncayo H; Reitsamer R
Arch Gynecol Obstet; 1992; 252(1):49-53. PubMed ID: 1417088
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy for gynecologic malignancies at Siriraj Hospital, Bangkok.
Senapad S
Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):656-9. PubMed ID: 3939044
[No Abstract] [Full Text] [Related]
17. [Does the addition of an anxiolytic drug improve the anti-emetic effectiveness of the steroid and granisetron combination in the prophylaxis of cisplatin-induced vomiting?].
Lehoczky O; Bagaméri A; Sárosi Z; Kulcsár T; Pulay T
Orv Hetil; 2001 Aug; 142(31):1681-4. PubMed ID: 11556262
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy in gynecological cancer: KCOG-G1301 phase II trial.
Abe M; Hirashima Y; Kasamatsu Y; Kado N; Komeda S; Kuji S; Tanaka A; Takahashi N; Takekuma M; Hihara H; Ichikawa Y; Itonaga Y; Hirakawa T; Nasu K; Miyagi K; Murakami J; Ito K
Support Care Cancer; 2016 Feb; 24(2):675-682. PubMed ID: 26130365
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy for gynecologic tumors].
Machover D
Contracept Fertil Sex; 1996 Apr; 24(4):264-7. PubMed ID: 8704799
[No Abstract] [Full Text] [Related]
20. [Kampo therapy for side effects of gynecologic carcinomatous chemotherapy].
Fushiki H
Nihon Rinsho; 2004 Oct; 62 Suppl 10():623-6. PubMed ID: 15535320
[No Abstract] [Full Text] [Related]
[Next] [New Search]
